Skip to content
HomeMedia CenterPress releases FinancialJohnson & Johnson to Participate in the 9th Annual SVB Leerink Global Healthcare Conference

Johnson & Johnson to Participate in the 9th Annual SVB Leerink Global Healthcare Conference

Share Article
share to

New Brunswick, NJ (Feb. 12, 2020) -- Johnson & Johnson (NYSE: JNJ) will participate in the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, Feb. 26th, at Lotte New York Palace, NY. Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 2:00 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately two hours after the live webcast.

Press Contacts:
Cristal Downing
(732) 524-3283
(908) 616-8833 (M)

Investor Contacts:
Matt Stuckley
(732) 524-2617

You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.